6-12 years, the prevalence of ASD in China was reported to be 0.7% in 2020 [3]. The mission to improve the screening, diagnosis, rehabilitation, and assistance of ASD children aged 0-6 years has been listed in the national strategic deployments for the next decade, including the Outline for the Development of Children in China (2021-2030) and the China Brain Project 2030.Although ASD is highly heritable, the biological underpinnings and development over the lifespan remain largely unclear due to its heterogeneity. To address these challenges, large-scale sample collections focusing on the early developmental period of ASD are essential, as these are critical for identifying ways of screening high-risk
Why Was the Cohort Set Up?Autism spectrum disorder (ASD) is a child neurodevelopmental disorder, the onset of which is generally within 3 years of age, and often leads to lifelong impaired social and cognitive functions, which impose significant mental pressure and economic burdens on the family and society. In 2012, the incidence data released by the World Health Organization showed that the global prevalence of ASD was ~0.625% [1], and the latest report from the Centers for Disease Control and Prevention show that the incidence of ASD in the USA had reached 2.3% in 2021 [2]. According to a nationwide survey of over 120,000 children aged www.neurosci.cn www.springer.com/12264 Yuan Dai, Yuqi Liu contributed equally to this work.